These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

821 related items for PubMed ID: 16359229

  • 1. Recognition patterns of HLA-A2-restricted human immunodeficiency virus-1-specific cytotoxic T-lymphocytes in a cohort of HIV-1-infected individuals.
    Schmitt-Haendle M, Bachmann O, Harrer E, Schmidt B, Bäuerle M, Harrer T.
    Viral Immunol; 2005; 18(4):627-36. PubMed ID: 16359229
    [Abstract] [Full Text] [Related]

  • 2. The HIV-1 HLA-A2-SLYNTVATL is a help-independent CTL epitope.
    Kan-Mitchell J, Bisikirska B, Wong-Staal F, Schaubert KL, Bajcz M, Bereta M.
    J Immunol; 2004 May 01; 172(9):5249-61. PubMed ID: 15100263
    [Abstract] [Full Text] [Related]

  • 3. Efficient processing of the immunodominant, HLA-A*0201-restricted human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequences.
    Brander C, Yang OO, Jones NG, Lee Y, Goulder P, Johnson RP, Trocha A, Colbert D, Hay C, Buchbinder S, Bergmann CC, Zweerink HJ, Wolinsky S, Blattner WA, Kalams SA, Walker BD.
    J Virol; 1999 Dec 01; 73(12):10191-8. PubMed ID: 10559335
    [Abstract] [Full Text] [Related]

  • 4. Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term nonprogressing HIV-1-infected individual.
    Harrer T, Harrer E, Barbosa P, Kaufmann F, Wagner R, Brüggemann S, Kalden JR, Feinberg M, Johnson RP, Buchbinder S, Walker BD.
    J Immunol; 1998 Nov 01; 161(9):4875-81. PubMed ID: 9794421
    [Abstract] [Full Text] [Related]

  • 5. Absence of immunodominant anti-Gag p17 (SL9) responses among Gag CTL-positive, HIV-uninfected vaccine recipients expressing the HLA-A*0201 allele.
    Ferrari G, Neal W, Ottinger J, Jones AM, Edwards BH, Goepfert P, Betts MR, Koup RA, Buchbinder S, McElrath MJ, Tartaglia J, Weinhold KJ.
    J Immunol; 2004 Aug 01; 173(3):2126-33. PubMed ID: 15265949
    [Abstract] [Full Text] [Related]

  • 6. An HLA-directed molecular and bioinformatics approach identifies new HLA-A11 HIV-1 subtype E cytotoxic T lymphocyte epitopes in HIV-1-infected Thais.
    Bond KB, Sriwanthana B, Hodge TW, De Groot AS, Mastro TD, Young NL, Promadej N, Altman JD, Limpakarnjanarat K, McNicholl JM.
    AIDS Res Hum Retroviruses; 2001 May 20; 17(8):703-17. PubMed ID: 11429111
    [Abstract] [Full Text] [Related]

  • 7. Study of antigen-processing steps reveals preferences explaining differential biological outcomes of two HLA-A2-restricted immunodominant epitopes from human immunodeficiency virus type 1.
    Cohen WM, Bianco A, Connan F, Camoin L, Dalod M, Lauvau G, Ferriès E, Culmann-Penciolelli B, van Endert PM, Briand JP, Choppin J, Guillet JG.
    J Virol; 2002 Oct 20; 76(20):10219-25. PubMed ID: 12239297
    [Abstract] [Full Text] [Related]

  • 8. Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses.
    Klein MR, van der Burg SH, Hovenkamp E, Holwerda AM, Drijfhout JW, Melief CJ, Miedema F.
    J Gen Virol; 1998 Sep 20; 79 ( Pt 9)():2191-201. PubMed ID: 9747728
    [Abstract] [Full Text] [Related]

  • 9. Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection.
    Yokomaku Y, Miura H, Tomiyama H, Kawana-Tachikawa A, Takiguchi M, Kojima A, Nagai Y, Iwamoto A, Matsuda Z, Ariyoshi K.
    J Virol; 2004 Feb 20; 78(3):1324-32. PubMed ID: 14722287
    [Abstract] [Full Text] [Related]

  • 10. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART).
    Gray CM, Lawrence J, Schapiro JM, Altman JD, Winters MA, Crompton M, Loi M, Kundu SK, Davis MM, Merigan TC.
    J Immunol; 1999 Feb 01; 162(3):1780-8. PubMed ID: 9973442
    [Abstract] [Full Text] [Related]

  • 11. Antagonism of cytotoxic T lymphocyte-mediated lysis by natural HIV-1 altered peptide ligands requires simultaneous presentation of agonist and antagonist peptides.
    Sewell AK, Harcourt GC, Goulder PJ, Price DA, Phillips RE.
    Eur J Immunol; 1997 Sep 01; 27(9):2323-9. PubMed ID: 9341776
    [Abstract] [Full Text] [Related]

  • 12. Specific recognition of lamivudine-resistant HIV-1 by cytotoxic T lymphocytes.
    Schmitt M, Harrer E, Goldwich A, Bäuerle M, Graedner I, Kalden JR, Harrer T.
    AIDS; 2000 Apr 14; 14(6):653-8. PubMed ID: 10807188
    [Abstract] [Full Text] [Related]

  • 13. Sequence conservation of subdominant HLA-A2-binding CTL epitopes in HIV-1 clinical isolates and CD8+ T-lymphocyte cross-recognition may explain the immune reaction in infected individuals.
    Thorn M, Tang S, Therrien D, Kløverpris H, Vinner L, Kronborg G, Gerstoft J, Corbet S, Fomsgaard A.
    APMIS; 2007 Jun 14; 115(6):757-68. PubMed ID: 17550385
    [Abstract] [Full Text] [Related]

  • 14. Cross-Reactivity Between Influenza Matrix- and HIV-1 P17-Specific CTL-A Large Cohort Study.
    Hückelhoven AG, Etschel JK, Bergmann S, Zitzelsberger K, Mueller-Schmucker SM, Harrer EG, Harrer T.
    J Acquir Immune Defic Syndr; 2015 Aug 15; 69(5):528-35. PubMed ID: 25900164
    [Abstract] [Full Text] [Related]

  • 15. Degeneracy and repertoire of the human HIV-1 Gag p17(77-85) CTL response.
    Kan-Mitchell J, Bajcz M, Schaubert KL, Price DA, Brenchley JM, Asher TE, Douek DC, Ng HL, Yang OO, Rinaldo CR, Benito JM, Bisikirska B, Hegde R, Marincola FM, Boggiano C, Wilson D, Abrams J, Blondelle SE, Wilson DB.
    J Immunol; 2006 Jun 01; 176(11):6690-701. PubMed ID: 16709828
    [Abstract] [Full Text] [Related]

  • 16. Novel and promiscuous CTL epitopes in conserved regions of Gag targeted by individuals with early subtype C HIV type 1 infection from southern Africa.
    Masemola AM, Mashishi TN, Khoury G, Bredell H, Paximadis M, Mathebula T, Barkhan D, Puren A, Vardas E, Colvin M, Zijenah L, Katzenstein D, Musonda R, Allen S, Kumwenda N, Taha T, Gray G, McIntyre J, Karim SA, Sheppard HW, Gray CM, HIVNET 028 Study Team.
    J Immunol; 2004 Oct 01; 173(7):4607-17. PubMed ID: 15383595
    [Abstract] [Full Text] [Related]

  • 17. Discovery and characterization of highly immunogenic and broadly recognized mimics of the HIV-1 CTL epitope Gag77-85.
    Boggiano C, Moya R, Pinilla C, Bihl F, Brander C, Sidney J, Sette A, Blondelle SE.
    Eur J Immunol; 2005 May 01; 35(5):1428-37. PubMed ID: 15789356
    [Abstract] [Full Text] [Related]

  • 18. Patterns of immunodominance in HIV-1-specific cytotoxic T lymphocyte responses in two human histocompatibility leukocyte antigens (HLA)-identical siblings with HLA-A*0201 are influenced by epitope mutation.
    Goulder PJ, Sewell AK, Lalloo DG, Price DA, Whelan JA, Evans J, Taylor GP, Luzzi G, Giangrande P, Phillips RE, McMichael AJ.
    J Exp Med; 1997 Apr 21; 185(8):1423-33. PubMed ID: 9126923
    [Abstract] [Full Text] [Related]

  • 19. Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection.
    Brander C, Hartman KE, Trocha AK, Jones NG, Johnson RP, Korber B, Wentworth P, Buchbinder SP, Wolinsky S, Walker BD, Kalams SA.
    J Clin Invest; 1998 Jun 01; 101(11):2559-66. PubMed ID: 9616227
    [Abstract] [Full Text] [Related]

  • 20. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1.
    Tsomides TJ, Aldovini A, Johnson RP, Walker BD, Young RA, Eisen HN.
    J Exp Med; 1994 Oct 01; 180(4):1283-93. PubMed ID: 7523570
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.